LIVE PULSE
5.0 Anthropic CEO Amodei calls for slower AI development and shared safety rules — 11 src2.7 Agility Robotics unveils Digit 5 humanoid for warehouses and factories — 2 src2.5 Apple ships rebuilt Siri with Google Gemini, but not in the EU — 2 src2.2 Siri AI in macOS 27 Golden Gate: FAQ, Germany availability, privacy questions — 2 src1.7 Sam Altman says OpenAI will not go public in 2026, citing AI safety concerns — 5 src1.4 OpenAI contractors review real ChatGPT conversations to rate responses, report says — 2 src1.3 Anthropic data retention policy prompts firms to limit Claude use for sensitive work — 1 src1.3 Study traces LLM hallucinations to competing latent associations — 1 src1.3 Arabic-Russian Parallel Corpus and LLM Benchmark for Scientific Text — 1 src1.3 Study Analyzes Self-Reported Limitations in NLP Research — 1 src5.0 Anthropic CEO Amodei calls for slower AI development and shared safety rules — 11 src2.7 Agility Robotics unveils Digit 5 humanoid for warehouses and factories — 2 src2.5 Apple ships rebuilt Siri with Google Gemini, but not in the EU — 2 src2.2 Siri AI in macOS 27 Golden Gate: FAQ, Germany availability, privacy questions — 2 src1.7 Sam Altman says OpenAI will not go public in 2026, citing AI safety concerns — 5 src1.4 OpenAI contractors review real ChatGPT conversations to rate responses, report says — 2 src1.3 Anthropic data retention policy prompts firms to limit Claude use for sensitive work — 1 src1.3 Study traces LLM hallucinations to competing latent associations — 1 src1.3 Arabic-Russian Parallel Corpus and LLM Benchmark for Scientific Text — 1 src1.3 Study Analyzes Self-Reported Limitations in NLP Research — 1 src
HEATPULSEAI MAGAZINES
FLIP · FOLLOW · SAVE
Log inSign up

breast-cancer

topic2 events
papersTODAY 04:00 UTC

Causal multi-modal AI model predicts chemotherapy sensitivity in breast cancer

A new arXiv preprint describes a causal, multi-modal AI approach for predicting which breast cancer patients will benefit from chemotherapy. The authors argue that current reliance on recurrence scores as a stand-in for treatment benefit may drive unnecessary chemotherapy use. Their method aims to give clinicians a more personalized estimate of chemosensitivity.

medical-ai/multi-modal/causal-inference/breast-cancer
papersTODAY 04:00 UTC

Edge AI Medical Device System Tested for Breast Cancer Team Meetings

Researchers present a system that runs AI models locally on edge hardware as a regulated medical device, aimed at supporting breast cancer multidisciplinary team meetings. The paper reports a feasibility evaluation, noting that existing AI-supported workflows for these meetings depend on cloud infrastructure. The work targets reducing documentation burden and time pressure in complex case reviews.

medical-ai/edge-ai/healthcare/research